Drug discovery startup Insilico Medicine��alongside researchers from Harvard Medical School, Johns Hopkins School of Medicine, the Mayo Clinic, and others��used AI to identify more than two dozen gene targets related to amyotrophic lateral sclerosis (ALS). The research findings, which included 17 high-confidence and 11 novel therapeutic targets, were recently published in Frontiers in Aging��
]]>